Andrew Procter

4.2k total citations
55 papers, 2.2k citations indexed

About

Andrew Procter is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew Procter has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 19 papers in Pharmacology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew Procter's work include Alzheimer's disease research and treatments (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Andrew Procter is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Andrew Procter collaborates with scholars based in United Kingdom, United States and Mexico. Andrew Procter's co-authors include Paul T. Francis, David M. Bowen, Gary C. Stratmann, D. M. Bowen, Alan M. Palmer, Stephen L. Lowe, Elaine Murphy, A. Najlerahim, Neil R. Sims and David Neary and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain and Annals of Neurology.

In The Last Decade

Andrew Procter

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Procter United Kingdom 25 937 729 508 506 500 55 2.2k
Pierre Étienne Canada 25 795 0.8× 516 0.7× 410 0.8× 357 0.7× 570 1.1× 57 2.0k
Garry Blessed United Kingdom 11 705 0.8× 849 1.2× 678 1.3× 409 0.8× 626 1.3× 15 2.0k
Pamela White United Kingdom 18 894 1.0× 764 1.0× 760 1.5× 215 0.4× 808 1.6× 37 2.6k
C. G. Gottfries Sweden 28 591 0.6× 539 0.7× 476 0.9× 594 1.2× 407 0.8× 68 2.1k
Hans Jörg Möbius Germany 16 618 0.7× 934 1.3× 863 1.7× 911 1.8× 452 0.9× 22 2.7k
C. G. Gottfries Sweden 30 889 0.9× 918 1.3× 497 1.0× 856 1.7× 514 1.0× 64 3.3k
C H van Dyck United States 9 968 1.0× 515 0.7× 314 0.6× 636 1.3× 446 0.9× 12 2.1k
Egemen Savaskan Switzerland 28 540 0.6× 1.0k 1.4× 297 0.6× 395 0.8× 791 1.6× 64 3.2k
Ronald J. Polinsky United States 29 684 0.7× 980 1.3× 397 0.8× 396 0.8× 831 1.7× 75 3.2k
C. Hock Switzerland 24 515 0.5× 1.5k 2.1× 517 1.0× 434 0.9× 614 1.2× 39 3.6k

Countries citing papers authored by Andrew Procter

Since Specialization
Citations

This map shows the geographic impact of Andrew Procter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Procter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Procter more than expected).

Fields of papers citing papers by Andrew Procter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Procter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Procter. The network helps show where Andrew Procter may publish in the future.

Co-authorship network of co-authors of Andrew Procter

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Procter. A scholar is included among the top collaborators of Andrew Procter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Procter. Andrew Procter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowen, D. M., Andrew Procter, David Mann, et al.. (2007). Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology. 196(4). 603–610. 55 indexed citations
2.
Procter, Andrew, et al.. (1999). Neurochemical Features of Frontotemporal Dementia. Dementia and Geriatric Cognitive Disorders. 10(Suppl. 1). 80–84. 103 indexed citations
3.
Procter, Andrew, Paul T. Francis, Chris Holmes, et al.. (1994). ?-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects. Acta Neuropathologica. 88(6). 545–552. 9 indexed citations
4.
Stratmann, Gary C., Matthew T. Webster, Paul T. Francis, Andrew Procter, & D. M. Bowen. (1994). Brain Membrane Serine Protease Activity in Human Cortex Compared with Rat: Implication for Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 5(2). 62–68. 11 indexed citations
5.
Harrison, Paul J., Andrew Procter, Tim Exworthy, et al.. (1993). Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state. Neuropathology and Applied Neurobiology. 19(1). 10–21. 48 indexed citations
6.
Ward, Tony, et al.. (1993). Assessment in Severe Dementia: The Guy's Advanced Dementia Schedule. Age and Ageing. 22(3). 183–189. 11 indexed citations
7.
Francis, Paul T., Courtney Holmes, Matthew T. Webster, et al.. (1993). Preliminary Neurochemical Findings in Non-Alzheimer Dementia due to Lobar Atrophy. Dementia and Geriatric Cognitive Disorders. 4(3-4). 172–177. 56 indexed citations
8.
Francis, Paul T., Neil R. Sims, Andrew Procter, & David M. Bowen. (1993). Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives. Journal of Neurochemistry. 60(5). 1589–1604. 191 indexed citations
9.
Procter, Andrew, Paul T. Francis, Gary C. Stratmann, & David M. Bowen. (1992). Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochemical Research. 17(9). 917–922. 57 indexed citations
10.
Procter, Andrew, Gary C. Stratmann, Paul T. Francis, et al.. (1991). Characterisation of the Glycine Modulatory Site of the N‐Methyl‐d‐Aspartate Receptor‐Ionophore Complex in Human Brain. Journal of Neurochemistry. 56(1). 299–310. 28 indexed citations
11.
Procter, Andrew. (1991). Enhancement of Recovery from Psychiatric Illness by Methylfolate. The British Journal of Psychiatry. 159(2). 271–272. 19 indexed citations
12.
Francis, Paul T., Andrew Procter, & D. M. Bowen. (1991). A Glycine Site as Therapeutic Targeta. Annals of the New York Academy of Sciences. 640(1). 184–188. 1 indexed citations
13.
Procter, Andrew, et al.. (1989). Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease. Journal of Neurochemistry. 53(3). 698–704. 97 indexed citations
14.
Francis, Paul T., Amanda Poynton, Stephen L. Lowe, et al.. (1989). Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem. Brain Research. 494(2). 315–324. 67 indexed citations
15.
Procter, Andrew, et al.. (1989). Loss of glycine-dependent radioligand binding to the receptor complex in patients with Alzheimer's disease. Neuroscience Letters. 101(1). 62–66. 52 indexed citations
16.
Bowen, David M., et al.. (1989). Pyramidal neuron loss and “glycine-site therapy”: A need for an animal model and study in late-life depression. Neurobiology of Aging. 10(5). 616–618. 5 indexed citations
17.
Procter, Andrew, Stephen L. Lowe, Alan M. Palmer, et al.. (1988). Topographical distribution of neurochemical changes in Alzheimer's disease. Journal of the Neurological Sciences. 84(2-3). 125–140. 113 indexed citations
18.
Procter, Andrew, Alan M. Palmer, Paul T. Francis, et al.. (1988). Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease. Journal of Neurochemistry. 50(3). 790–802. 152 indexed citations
19.
Procter, Andrew, et al.. (1987). MOOD AND BEHAVIOUR PROBLEMS FOLLOWING THE RELOCATION OF ELDERLY PATIENTS WITH MENTAL ILLNESS. Age and Ageing. 16(6). 355–365. 45 indexed citations
20.
Hale, Anthony S., Andrew Procter, & P. K. Bridges. (1987). Clomipramine, Tryptophan and Lithium in Combination for Resistant Endogenous Depression: Seven Case Studies. The British Journal of Psychiatry. 151(2). 213–217. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Étienne Breakdown of academic impact, for papers by Garry Blessed Breakdown of academic impact, for papers by Pamela White Breakdown of academic impact, for papers by C. G. Gottfries Breakdown of academic impact, for papers by Hans Jörg Möbius Breakdown of academic impact, for papers by C. G. Gottfries Breakdown of academic impact, for papers by C H van Dyck Breakdown of academic impact, for papers by Egemen Savaskan Breakdown of academic impact, for papers by Ronald J. Polinsky Breakdown of academic impact, for papers by C. Hock
Rankless by CCL
2026